A domestic knowledge-based company has developed a specialized software used by pharmaceutical companies for medicinal production.
The patent of SSDD software for designing mimetic drugs with bio-pharmaceutical properties has been developed and is held exclusively by Avin Zist Kimia Dadeh Company, according to the CEO of the knowledge-based company.
“In this knowledge-based company, we’ve established a capable research and development unit by using the elite youth to work on medicines that cannot be produced domestically, or their import faces challenges,” Soroush Sardari was also quoted as saying by the news portal of the Vice-Presidency for Science and Technology.
The software helps produce new placebo compounds against mycobacterium species and HIV virus in silico (conducted or produced by means of computer modeling or simulation) with the desired therapeutic or biological capabilities, in addition to optimizing standard pharmaceutical compounds.
Add new comment